Stocks and InvestingStocks and Investing
Thu, April 18, 2019
Wed, April 17, 2019
Tue, April 16, 2019
Mon, April 15, 2019
Fri, April 12, 2019
Thu, April 11, 2019
Wed, April 10, 2019
Tue, April 9, 2019
Mon, April 8, 2019
Fri, April 5, 2019

Michelle Gilson Maintained (ASND) at Strong Buy with Increased Target to $133 on, Apr 5th, 2019


Published on 2024-10-26 12:56:34 - WOPRAI, Michelle Gilson
  Print publication without navigation


Michelle Gilson of Canaccord Genuity, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Increased Target from $132 to $133 on, Apr 5th, 2019.

Michelle has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with Michelle's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Michelle


  • Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $139 on, Friday, March 29th, 2019
  • Joseph Schwartz of "Leerink Swann" Upgraded from Hold to Buy and Increased Target to $90 on, Thursday, January 24th, 2019